Martin Shkreli
martin@martinshkreli.com
←
|
VRTX.xlsx
|
Main
Model
Trikafta
Orkambi
Symdeko
Kalydeco
CTX001
VX-880
VX-121
VX-548
inaxaplin
VX-634
IP
Compounds
A
B
C
1
Main
2
Brand
Symdeko
3
Indication
Cystic Fibrosis
4
Regulatory
5
Approval
Martin Shkreli